Rebright Partners is an Asia focus early stage venture capital firm. Backed by publicly listed Japanese Internet companies and prominent Super entrepreneur angel investors, investing in early stage tech startups around Asia.

In addition to the knowledge and capability in IT industry, our solid network in SouthEast Asia, India and Japan can be a springboard for the startups that are keen to expand to these regions and build partnerships with the biggest tech companies there.

Rebright Partners team is based in Singapore, Tokyo, and India Bangalore.

TEAM

  • Takeshi Ebihara
    Takeshi Ebihara Founding General Partner

    Ebihara has been in the industry 20 years as Venture Capitalist, as well as serial entrepreneur himself.
    Also founded and managed several internet companies himself includes stock-ex listed public company.
    He is mentoring at many accelerators, speaking for a lot of startup events to contribute startup ecosystem. He is a board member of many startup companies in SE Asia and Japan.

  • Brij Bhasin
    Brij Bhasin Principal - India Investment Lead

    Brij leads Rebright Partner’s investments in India. Prior to Rebright, he was part of founding team of GSF Accelerator, one of India’s largest and oldest Accelerator program. He was and advisor and part of early team at Little Eye Labs which was acquired by Facebook 2014. He has built world class technology products for over 12 years as part of several startups in India and US.  He is a Computer Science graduate from the University of Minnesota, USA.

  • Hironori Ishizaki
    Hironori Ishizaki Senior Analyst

    Hironori is responsible for raising the funds and managing the portfolios. Prior to Rebright, he was Japan Desk head at Corporate Catalyst India, one of the largest accounting firms in India, in charge of India investment advisory. He was also official advisor to Japanese Governmental organization in West India in 2014. He graduated from University of Tokyo, with major in French Philosophy, and obtained the professional qualification of U.S.CPA.